Submitted by kBLASTER Team on
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Nipro Diagnostics, Inc., announced today that the U.S. Food and Drug Administration (FDA) has 510(k) cleared its TRUE METRIX® AIR Self-Monitoring blood glucose system - a device for people with diabetes to test blood glucose and deliver data wirelessly to a smartphone.
As the diabetes store-brand leader and largest U.S. manufacturer of diabetes products for the store brand market, Nipro Diagnostics made the announcement to healthcare executives attending the National Association of Chain Drug Stores Annual Meeting in Palm Beach, Florida.
“Our new TRUE METRIX AIR Self-Monitoring blood glucose system is technology with reach,” said Scott Verner, CEO and President of Nipro Diagnostics. “Nipro Diagnostics’ customers have a better way to deliver superior health and wellness products that empower people with diabetes and their health support network to make better decisions for a healthier life,” continued Verner.
Looking for the cornerstone to a successful 510(k) clearance strategy? kBLASTER® FDA 510(k) search can quickly identify the best available primary predicate, multiple predicates or reference devices and manage those results effectively.